Cargando…

Targeting flexibility: a structure-based computational study revealing allosteric HIV-1 protease inhibitors

Detalles Bibliográficos
Autores principales:	Kunze, Jens, Todoroff, Nickolay, Rodrigues, Tiago, Schneider, Petra, Schneider, Gisbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980194/ http://dx.doi.org/10.1186/1758-2946-6-S1-P48

Ejemplares similares

Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for ‘Orphan’ Molecules
por: Reutlinger, Michael, et al.
Publicado: (2013)

Fractal Dimensions of Macromolecular Structures
por: Todoroff, Nickolay, et al.
Publicado: (2014)

Target prediction by cascaded self-organizing maps for ligand de-orphaning and side-effect investigation
por: Reker, Daniel, et al.
Publicado: (2014)

Go with the flow: de-orphaning focused combinatorial libraries
por: Reutlinger, Michael, et al.
Publicado: (2014)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
por: Kourjian, G, et al.
Publicado: (2012)

The orally bioavailable allosteric CXCR4 HIV-1 entry inhibitor AMD11070
por: Fricker, Simon, et al.
Publicado: (2012)

SBE13, a newly identified inhibitor of inactive polo-like kinase 1
por: Keppner, Sarah, et al.
Publicado: (2010)

Metabolic complications during HIV-treatment with protease inhibitors in patients from Braşov
por: Cocuz, Maria-Elena, et al.
Publicado: (2014)

Scrutinizing MHC-I Binding Peptides and Their Limits of Variation
por: Koch, Christian P., et al.
Publicado: (2013)

Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma
por: Cingolani, A, et al.
Publicado: (2010)

Disturbance of HDL apolipoprotein AI metabolism in severe hyperlipidemic and lipodystrophic HIV patients on a protease inhibitor treatment
por: Ouguerram, Khadija, et al.
Publicado: (2010)

Inhibitors of Helicobacter pylori Protease HtrA Found by ‘Virtual Ligand’ Screening Combat Bacterial Invasion of Epithelia
por: Löwer, Martin, et al.
Publicado: (2011)

Molecular modelling studies of synthesized pentacyclo-undecane peptides as potential HIV-1 wild type C-SA protease inhibitors
por: Honarparvar, Bahareh, et al.
Publicado: (2013)

Naturally occurring protease inhibitor resistance mutations and their frequencies in HIV proviral sequences of drug-naïve sex workers in Nairobi, Kenya
por: Sampathkumar, Raghavan, et al.
Publicado: (2014)

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients
por: Ménard, A, et al.
Publicado: (2014)

Immunoregulatory role of secretory leukocyte protease inhibitor in allergic asthma
por: Marino, Rafael, et al.
Publicado: (2010)

Study of changes in lipid profile and fasting blood glucose in protease inhibitor exposed HIV/AIDS patients in School of Tropical Medicine, Kolkata
por: Bhowmik, Ananya, et al.
Publicado: (2012)

Allosteric modulation of peptide ligand binding to Neuropeptide Y receptor Y1 revealed by fluorescence-based assay
por: Veiksina, Santa, et al.
Publicado: (2015)

Computational fragment-based drug design to explore the hydrophobic subpocket of the mitotic kinesin Eg5 allosteric binding site
por: Oguievetskaia, Ksenia, et al.
Publicado: (2010)

A novel HIV vaccine targets the 12 protease cleavage sites
por: Luo, M, et al.
Publicado: (2012)

Relating protease inhibitor resistance at time of virological failure with drug exposure
por: Van Luin, M, et al.
Publicado: (2010)

Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients
por: Macías, J, et al.
Publicado: (2010)

Novel positive allosteric modulators of sigma-1 receptor
por: Vavers, Edijs, et al.
Publicado: (2015)

A bioinformatic approach to identify new potential resistance relevant amino acid substitutions (AAS) in HIV-1 protease (H1P)
por: Frederiksen, Casper M, et al.
Publicado: (2009)

Prevalence of drug resistance mutations in HIV-1 protease gene from North India
por: Azam, Mohd, et al.
Publicado: (2012)

Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice
por: Llibre, JM, et al.
Publicado: (2010)

Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens
por: Marcelin, AG, et al.
Publicado: (2010)

Potential immune of recombinant serine protease of Corynebacterium pseudotuberculosis
por: Almeida, Daniela Droppa, et al.
Publicado: (2014)

HIV Gag and PR: partners in resistance to protease and maturation inhibitors
por: Nijhuis, Monique
Publicado: (2011)

P16-39. T cell recognition of autologous and non-autologous HIV-1 protease peptides by HIV-1 infected patients undergoing PI therapy
por: Moraes, SL, et al.
Publicado: (2009)

RNA remarkably promotes HIV-1 protease fast turnover for NCp15 processing in mild acidic conditions leading to condensation of HIV-1 nucleocapsid
por: Lyonnais, Sebastien, et al.
Publicado: (2013)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

Go with the flow and accessorize your drugs
por: Schneider, Gisbert
Publicado: (2014)

Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist
por: Rupp, Matthias, et al.
Publicado: (2010)

Effect of lipemia and bilirubinemia on HIV-1 protease and reverse transcriptase genotyping and phenotyping success: a five-year analysis
por: Pattery, T, et al.
Publicado: (2010)

Placement of p6pol between tandem repeat HIV-1 protease domains reduces Gag cleavage efficiency
por: Chou, Tin-An, et al.
Publicado: (2013)

HIV drug resistance profile of HIV-1 CRF 01_AE protease and integrase coding regions in HIV infected Cambodian patients failing LPV-based 2(nd) line antiretroviral regimen
por: Nouhin, Janin, et al.
Publicado: (2011)

Allosteric regulation by non peptidic, low molecular weight compounds of CCR5 coupling to g-proteins and interaction with Gp120 - consequences on inhibition of R5 HIV-1 infection
por: Rueda, Patricia, et al.
Publicado: (2010)

The SpineML toolchain: enabling computational neuroscience through flexible tools for creating, sharing, and simulating neural models
por: Cope, Alexander J, et al.
Publicado: (2014)

Computational studies of flaviviruses: approaching to novel fusion inhibitors
por: Osolodkin, Dmitry I, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5vjmcoggbqaomrokm824l0m79e